DPP4 and brain disorder: GLP-1 has a short half-life and is inactivated by the DPP-IV enzyme; however, GLP1-Rs are not cleaved by DPP-IV and can cross the blood–brain barrier (BBB); thus, they are important candidates for treating brain diseases.